SCHEMBL4380087

SCHEMBL4380087

O=C(O)c1ncsc1-c1ccc(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
ALPL P05186 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
CRHBP P24387 1/20 0.44
RAB9A P51151 1/20 0.44
CRHR2 Q13324 1/20 0.44
SRD5A2 P31213 1/20 0.43
ALDH1A1 P00352 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
CASP1 P29466 1/20 0.42
MARS1 P56192 1/20 0.41
EIF4E P06730 1/20 0.40
PRKD3 O94806 1/20 0.40
PRKCG P05129 1/20 0.40
PRKCB P05771 1/20 0.40
IL1R1 P14778 1/20 0.40
PRKCA P17252 1/20 0.40
TNFRSF1A P19438 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9585956 0.88 KDM4E (0.51) KDM4ESMN1; SMN2NPC1CRHBPRAB9A
SCHEMBL13398672 0.84 KDM4E (0.50) KDM4EALDH1A1TP53EIF4EDHODH
SCHEMBL4371383 0.83 ALPL (0.49) KDM4EALPLSMN1; SMN2NPC1RAB9A
SCHEMBL13398544 0.81 KDM4E (0.63) KDM4EALPLSMN1; SMN2NPC1RAB9A
SCHEMBL9587747 0.81 CNR1 (0.43) ALPLPRKD3PRKCGPRKCBIL1R1
SCHEMBL9587799 0.80 MAPT (0.53) KDM4ESMN1; SMN2NPC1RAB9ATSHR
SCHEMBL10432896 0.78 SMN1; SMN2 (0.39) KDM4EALPLSMN1; SMN2NPC1CRHBP
Hydrochloric Acid SCHEMBL9586015 0.77 PMP22 (0.56) ALPLTSHRTDP1
SCHEMBL9585511 0.76 KDM4E (0.55) KDM4ETSHREIF4ETLR7GRM1
SCHEMBL4373610 0.76 RORB (0.46) KDM4EALPLSMN1; SMN2NPC1CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed
US-5204482-A Ethylenediamine monoamide heteroaryl derivatives HOFFMAN-LAROCHE INC. (US) 1993-04-20 US disclosed
US-5011849-A Monoamine oxidase inhibitors HOFFMANN-LA ROCHE INC. (US) 1991-04-30 US disclosed
EP-0352581-A2 Ethylene diaminmonoamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 1990-01-31 EP disclosed